Article by Colette Gallagher, Public Affairs
Is irritable bowel syndrome (IBS) a gut microbiota-related disorder? That is the question Purna Kashyap, M.B.B.S., consultant in gastroenterology, associate director of the Mayo Clinic Center for Individualized Medicine Microbiome Program, and Mayo Clinic researchers wanted to answer as they analyzed studies about gut microbiota and IBS.
The study, published in the American Journal of Physiology—Gastrointestinal and Liver Physiology helps connect the dots between gut microbiota and development of IBS.
According to the authors, the outlook is optimistic, and they now have the necessary tools and the knowledge as they embark on developing effective microbiota targeted therapies for IBS.
Learn more about the role of the microbiome in health and disease
Save the date for the next Individualizing Medicine Conference on Oct. 9-11, 2017.